Discussion Topic: Class 1C Antiarrhythmics for Premature Ventricular Complex Suppression in Nonischemic Cardiomyopathy With Implantable Cardioverter-Defibrillators
William H. Sauer, MD, FHRS, CCDS, Brigham and Women’s Hospital is joined by Edward P. Gerstenfeld, MD, MS, FHRS, University of California, San Francisco, and Yasser Rodriguez, MBA, MD, Cleveland Clinic Florida to discuss premature ventricular complexes (PVCs) are common and associated with worse outcomes in patients with heart failure. Class 1C antiarrhythmic drugs (AADs) effectively suppress PVCs, but guidelines currently restrict their use in structural heart disease.
Host: William Sauer, MD, FHRS, CCDS
Guests: Edward Gerstenfeld, MD, MS, FHRS & Yasser Rodriguez, MBA, MD
Speaker and Article Information: Download
Topic
- The Lead
Resource Type
- Podcasts
Related Resources
The Lead
Podcasts
The Lead Episode 136: A Discussion of Electrophysiological Characteristics of Lead Position Dependent Electrogram Uninterrupted Transition during Left Bundle Branch Pacing
February 12, 2026
HRX Next
Podcasts
HRX NeXt Ep. 7 – A Conversation About Managing Data Overload: AI, Wearables, and Apps
February 6, 2026
The Lead
Podcasts
The Lead Episode 135: A Discussion of Mechanical Vacuum Aspiration and Debulking of Large Vegetations During Cardiac Implantable Electronic Device Extractions
February 5, 2026